The European Commission has approved a new subcutaneous (under-the-skin) formulation of Sarclisa (isatuximab), a treatment for multiple myeloma that was previously available in…
Latest news & perspectives
The U.S. Food and Drug Administration (FDA) has approved a new formulation of the anticancer therapy nilotinib, branded Cavhanza, to treat certain people with chronic…
Ideaya Biosciences and Roche announced a collaboration to test two experimental treatments for pancreatic cancer in combination. The companies will test Ideaya’s…
